Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey. (January 2022)
- Record Type:
- Journal Article
- Title:
- Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey. (January 2022)
- Main Title:
- Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey
- Authors:
- Chen, Yan
Sun, Lu
Ba, Xiaoliang
Jiang, Shengnan
Zhuang, Hemu
Zhu, Feiteng
Wang, Haiping
Lan, Peng
Shi, Qiucheng
Wang, Zhengan
Chen, Yiyi
Shi, Keren
Ji, Shujuan
Jiang, Yan
Holmes, Mark A.
Yu, Yunsong - Abstract:
- Abstract: Objectives: The aim of this study was to investigate the genomic epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in China to identify predominant lineages and their associations with clinical data and antimicrobial resistance profiles. Methods: We performed a national prevalence study of patients with S. aureus infections in 22 tertiary hospitals in China from 2015 to 2017. Clinical data from patients and the antimicrobial phenotypes were collected for each isolate. Genome sequencing was performed on a proportion of isolates and a phylogenetic analysis was undertaken. Genotypic and phenotypic β-lactam susceptibilities were compared. Results: A total of 1900 patients with S. aureus infections were included, of which 40% involved MRSA. Community-associated MRSA (CA-MRSA) infections were 24% of the total isolates. Genomic data showed that more than three-quarters of the MRSA were from three dominant lineages CC239 (25%, 116/471), CC5 (21%, 96/471) and CC59 (33%, 154/471) with CC59 accounting for more than half of the CA-MRSA isolates. Penicillin susceptibility genomic features were observed in 53% (251/470) of MRSA, including almost all of the CC59 (152/154) lineage, and 96% (242/251) of these isolates demonstrated in vitro susceptibility to penicillin or amoxicillin combined with clavulanic acid. Phylogenetic analysis indicated that the CC59 lineage can be divided into six lineages with all Asian CC59 isolates likely arising from an ancestralAbstract: Objectives: The aim of this study was to investigate the genomic epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in China to identify predominant lineages and their associations with clinical data and antimicrobial resistance profiles. Methods: We performed a national prevalence study of patients with S. aureus infections in 22 tertiary hospitals in China from 2015 to 2017. Clinical data from patients and the antimicrobial phenotypes were collected for each isolate. Genome sequencing was performed on a proportion of isolates and a phylogenetic analysis was undertaken. Genotypic and phenotypic β-lactam susceptibilities were compared. Results: A total of 1900 patients with S. aureus infections were included, of which 40% involved MRSA. Community-associated MRSA (CA-MRSA) infections were 24% of the total isolates. Genomic data showed that more than three-quarters of the MRSA were from three dominant lineages CC239 (25%, 116/471), CC5 (21%, 96/471) and CC59 (33%, 154/471) with CC59 accounting for more than half of the CA-MRSA isolates. Penicillin susceptibility genomic features were observed in 53% (251/470) of MRSA, including almost all of the CC59 (152/154) lineage, and 96% (242/251) of these isolates demonstrated in vitro susceptibility to penicillin or amoxicillin combined with clavulanic acid. Phylogenetic analysis indicated that the CC59 lineage can be divided into six lineages with all Asian CC59 isolates likely arising from an ancestral Mainland China lineage. Conclusions: This study showed a high prevalence of CA-MRSA in China, largely due to the widespread presence of CC59. As almost all isolates in this lineage possess genetic variants leading to increased β-lactam susceptibility, we suggest that to improve antibiotic stewardship combinations of penicillins and β-lactamase inhibitors should be included in the antibiotic susceptibility testing panels used to inform treatment decisions and research undertaken on this combination therapy. … (more)
- Is Part Of:
- Clinical microbiology and infection. Volume 28:Number 1(2022)
- Journal:
- Clinical microbiology and infection
- Issue:
- Volume 28:Number 1(2022)
- Issue Display:
- Volume 28, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 28
- Issue:
- 1
- Issue Sort Value:
- 2022-0028-0001-0000
- Page Start:
- 85
- Page End:
- 92
- Publication Date:
- 2022-01
- Subjects:
- China -- Community -- Genome sequencing -- Penicillin -- Staphylococcus aureus
Medical microbiology -- Periodicals
Diagnostic microbiology -- Periodicals
Communicable diseases -- Periodicals
Infection -- Periodicals
616.01 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1469-0691 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.cmi.2021.05.024 ↗
- Languages:
- English
- ISSNs:
- 1198-743X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.305520
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20272.xml